A phase 3 trial of Purified-exosome-product-RION for treatment of Diabetic-foot-ulcer
Latest Information Update: 25 Jan 2025
Price :
$35 *
At a glance
- Drugs Purified exosome product RION (Primary)
- Indications Diabetic foot ulcer
- Focus Registrational; Therapeutic Use
- 25 Jan 2025 New trial record
- 13 Jan 2025 According to a RION media release, upon successful completion of phase 2a trial, RION plans to initiate a pivotal Phase 3 study, with the goal of filing a Biologics License Application (BLA) with the U.S. Food and Drug Administration (FDA).